Back | Next |
home / stock / kalv / kalv message board
Subject | By | Source | When |
---|---|---|---|
http://m.nasdaq.com/article/sv-life-sciences-advisers-llc-buys-kalvista-pharmace | kondziu | investorshub | 02/10/2017 10:38:41 AM |
$8.25 now ~ keep rollin | Warchest | investorshub | 01/09/2017 8:20:18 PM |
any positive news and volume will move this north | ming1234 | investorshub | 01/09/2017 8:10:52 PM |
$LIVE action starting !!! | Warchest | investorshub | 01/09/2017 6:35:11 PM |
watching close ~ | Warchest | investorshub | 01/09/2017 6:30:21 PM |
The way this is dropping, there has to | Toxic Avenger | investorshub | 12/12/2016 4:01:25 PM |
So when will CBYL holders be issued $KALV | MSparks6 | investorshub | 11/22/2016 3:06:28 PM |
$CBYL is now KALV with a 1:14 reverse | Toxic Avenger | investorshub | 11/22/2016 1:12:17 PM |
$6.00 | Iam_in | investorshub | 11/22/2016 1:08:15 PM |
New Ticker symbol now: KALV | Iam_in | investorshub | 11/22/2016 1:06:35 PM |
Correction : $5.49 PM | Iam_in | investorshub | 11/22/2016 1:03:46 PM |
WOW - look at this $0,89---> $4,60 | Iam_in | investorshub | 11/22/2016 1:01:49 PM |
Apparently the merger deal was approved by a | Toxic Avenger | investorshub | 11/22/2016 12:11:24 AM |
* * $CBYL Video Chart 11-21-16 * * | ClayTrader | investorshub | 11/21/2016 9:26:25 PM |
Attempting to break 0.72. GL to holders | beginneer | investorshub | 11/21/2016 2:49:42 PM |
We'll see how this goes. Hopefully back to | beginneer | investorshub | 11/21/2016 2:45:58 PM |
$CBYL continuing its upward momentum pre-market. | Toxic Avenger | investorshub | 11/21/2016 2:24:32 PM |
* * $CBYL Video Chart 11-18-16 * * | ClayTrader | investorshub | 11/18/2016 9:46:54 PM |
Oh okay. Im still up for it even | beginneer | investorshub | 11/18/2016 8:43:29 PM |
New buyer? They're not being bought, they're merging | Toxic Avenger | investorshub | 11/18/2016 7:59:44 PM |
News, Short Squeeze, Breakout and More Instantly...
KalVista Pharmaceuticals Inc. Company Name:
KALV Stock Symbol:
NASDAQ Market:
KalVista Pharmaceuticals Inc. Website:
- Regulatory filings planned for US, EU, UK and Japan to enable multiple 2025 commercial launches – - Development strategy refined for oral Factor XIIa program – - Organizational focus to drive results and set path to positive cash flow – KalVist...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that William C. Fairey has been appointed to the Company’s Board of Directors, ef...
2024-04-12 19:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...